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Abstract
Background: As a marker of Helicobacter pylori, Cytotoxin-associated gene A (cagA) has been revealed to be the major
virulence factor causing gastroduodenal diseases. However, the molecular mechanisms that underlie the development of
different gastroduodenal diseases caused by cagA-positive H. pylori infection remain unknown. Current studies are limited
to the evaluation of the correlation between diseases and the number of Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs in the CagA
strain. To further understand the relationship between CagA sequence and its virulence to gastric cancer, we proposed a
systematic entropy-based approach to identify the cancer-related residues in the intervening regions of CagA and
employed a supervised machine learning method for cancer and non-cancer cases classification.
Methodology: An entropy-based calculation was used to detect key residues of CagA intervening sequences as the gastric
cancer biomarker. For each residue, both combinatorial entropy and background entropy were calculated, and the entropy
difference was used as the criterion for feature residue selection. The feature values were then fed into Support Vector
Machines (SVM) with the Radial Basis Function (RBF) kernel, and two parameters were tuned to obtain the optimal F value
by using grid search. Two other popular sequence classification methods, the BLAST and HMMER, were also applied to the
same data for comparison.
Conclusion: Our method achieved 76% and 71% classification accuracy for Western and East Asian subtypes, respectively,
which performed significantly better than BLAST and HMMER. This research indicates that small variations of amino acids in
those important residues might lead to the virulence variance of CagA strains resulting in different gastroduodenal diseases.
This study provides not only a useful tool to predict the correlation between the novel CagA strain and diseases, but also a
general new framework for detecting biological sequence biomarkers in population studies.
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Introduction
Helicobacter pylori (H. pylori) is a Gram-negative helix-shaped
bacterium inhabiting the human stomach and infecting more than
half of the world’s population [1,2,3]. Recent studies have shown
that it is associated with gastroduodenal diseases, including
duodenal ulcers [4], gastric ulcers [5] and chronic gastritis. More
importantly, it is a significant risk factor for developing gastric
cancer [6,7,8]. It has been classified as a Class 1 human
carcinogen by the World Health Organization since 1994 [1].
As a marker of H. pylori, the Cytotoxin-associated gene A (cagA)
has been revealed by further analysis to be the major virulence
factor. H. pylori strains carrying the cagA gene increase the risk
factor of gastroduodenal diseases by three folds over cagA-negative
strains [6,9,10]. CagA, which is encoded by the cagA gene, is a
125–140 kDa protein. It contains 1142–1320 amino acids and has
a variable region at the C-terminal region in which various short
sequences (such as EPIYA motif) repeat 1–7 times. After H. pylori
colonizing on the surface of the gastric epithelium, CagA can be
translocated into the gastric epithelial cell through a type IV
secretion system. Once injected into the host cell, CagA localizes
to the plasma membrane and can be phosphorylated by Src-family
tyrosine kinases on the specific tyrosine residues of a five-amino-
acid (EPIYA) motif [11,12,13,14]. Tyrosine-phosphorylated CagA
then binds specifically to SHP-2 tyrosine phosphatase [11,15] to
activate a phosphorylase, which causes the cascade effect that
interferes with the signal transduction pathway of the host cell,
leading to a restructuring of the host cell cytoskeleton and
formation of hummingbird phenotype [11,16]. At the same time
through activating mitogen-activated protein kinase (MAPK),
extracellular signal-regulated kinase (ERK) [17] and focal
adhesion kinase (FAK), CagA also can cause cell dissociation
and infiltrative tumor growth [18,19,20,21]. Such a process makes
CagA a most important virulence factor in H. pylori [22].
Within the variable region of CagA, there are some different
intervening sequences between those EPIYA motifs. One copy of
EPIYA plus intervening sequence is identified as an EPIYA
segment. Four unique types of EPIYA segments have been found
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isolated from East Asian countries, designated as East Asian CagA,
contains EPIYA-A, EPIYA-B and EPIYA-D motifs. The CagA
from Western countries, EPIYA-D, is replaced by EPIYA-C.
Stronger phosphorylation motif binding activity of the EPIYA-D
motif leads to greater morphological changes than what the
EPIYA-C motif can cause in infected cells [11]. It is this EPIYA-D
motif’s increased binding activity and resultant morphological
changes that identifies it as a potential factor to explain the higher
incidence of gastric cancer in East Asian countries [23,24].
Previous studies revealed a variation in the number of EPIYA
motif repeats for both East Asian and Western CagA, which can
affect biological activities. Yamaoka et al. [25] found that in
Columbia and USA, the ability of cagA-positive H. pylori to cause
gastric mucosal atrophy and intestinal metaplasia might be related
to the number of EPIYA motifs in the CagA strain. Argent et al.
[16] came to the same conclusion later. However, contrary
opinions were published by Lai et al. [26] based on findings of no
relationship between the number of EPIYA motifs in the CagA
strain and clinical disease within 58 isolates from Taiwan.
Considering the size and geographic limitation of these studies,
the validity of this conclusion is questionable. Aside from the
number of the EPIYA motif repeats, the sequence difference of
strains in variable regions also could cause a significant difference
of virulence, which might relate to the different pathogenic
abilities of H. pylori [27].
Because of the complex and variant sequences in CagA, the
relationships between the polymorphism of CagA and clinical
diseases become a very interesting research problem. However, the
molecular mechanisms that underlie different gastroduodenal
diseases caused by cagA-positive H. pylori infection remain
unknown. Until now most studies are still limited to the discovery
or evaluation of the correlation between the number of CagA
EPIYA motifs and diseases [28].
In this paper, we propose a systematic method to analyze not
only the number of EPIYA motifs in CagA sequences but also the
specific sequence patterns of intervening regions. First, we
introduce entropy calculation to detect the residues within the
variable region of CagA as the gastric cancer biomarkers. Then we
employ a supervised learning procedure to classify cancer and
non-cancer by using the information of detected residues in CagA
as the features. We choose support vector machines (SVM) as a
binary classifier and compare our method with others. Our
approach not only proves our hypothesis that the sequence of
variable region of CagA contains information to distinguish
different diseases, but also provides a useful tool to predict the
correlation between the novel CagA strains and diseases and to
detect the biomarker as well.
Methods
Data Preprocessing
Based on the previous description in Ref. [15], we named the
EPIYA motif and the following intervening regions R1, R2, R3,
R39, R4 and R49 (Figure 1). Figure 2 shows the position relation
between the EPIYA motif (R1) and other intervening regions by
using the CagA types A-B-D (East Asian subtype) and A-B-C
(Western subtype) as examples. R2 is relatively conserved across
both subtypes, but there are significant differences between the
intervening regions R3 and R39, as well as between R4 and R49.
The East Asian subtype and the Western subtype were treated as
two independent groups. Their data was then processed and the
results were analyzed within each group individually.
All intervening regions were extracted from the CagA sequences
and put into the corresponding subtype groups, and then the
multiple sequence alignments were applied for each group
individually by using Clustal X version 2.0.3 [29]. The sequences
profiles (Figure 1) was built by using the Weblogo 3 [30].
Residue Detection
Since CagA is related to almost all gastroduodenal diseases and
simple analysis of EPIYA motif repeats does not yield any
statistically significant differences among those diseases, the
information indicating a specific disease might be hidden in the
intervening regions. This research assumes that there is a set of
residues or residue combinations that could be useful as a marker
of a specific disease. This study focuses on the gastric cancer and
uses the cancer/non-cancer groups as the example.
Based on the aligned sequences for each intervening region,
specific residues were identified by comparing the difference of
combinatorial entropy [31] between the cancer and non-cancer
groups. This procedure includes the following steps:
First of all, we divide the given multiple alignments for all
intervening regions into two groups: gastric cancer group and non-
cancer group. For each column of multiple alignments, we
compute the background entropy (Eq. 1) and the combinatorial
entropy (Eq. 2), described as follows:
Ci~
X
k
ln
Nk!
P
a~1:::20
Na,i,k!
ð1Þ
where Nk represents the number of sequences in group k. Na,i,k
indicates the number of residues of type a in the column i of group
k. Na,i is the number of residues of type a in the column i. N
represents the total number of sequences in alignment.
Bi~
X
k
ln
Nk!
P
a~1:::20
~ N Na,i,k!
ð2Þ
where ~ N Na,i,k~NkNa,i=N.
Then the entropy difference between the combinatorial entropy
and the background entropy is calculated:
DE~Ci{Bi ð3Þ
Figure 3 illustrates the entropy concept using three extreme
cases. In case P1, the amino acids are ‘randomly and uniformly
distributed’ over all groups and there is no significantly conserved
pattern for this position. Case P2 represents a ‘globally conserved’
pattern and all the amino acids are the same across both groups.
In case P3, some specific amino acids are only conserved in
particular groups, and different groups have different amino acids.
We call this case ‘locally conserved’.
According to the calculation results of the entropy difference for
the above three cases, the combinatorial entropy is Ci~0 for both
‘globally conserved’ and ‘locally conserved’ cases. For ‘randomly
and uniformly distributed’ case, Ci gets the maximum value. We
can distinguish the ‘conserved’ and ‘randomly and uniformly
distributed’ cases based on the combinatorial entropy, but it does
not help pick ‘locally conserved’ case from all ‘conserved’ cases.
When we consider the background entropy at the same time, Bi
gets the maximum value, 0 and medium value for the ‘randomly
and uniformly distributed’ case, ‘globally conserved’ case, ‘locally
conserved’ case, respectively. Finally, the differences for the above
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value. Hence, the entropy difference is a proper measurement for
detecting a ‘locally conserved’ sequence pattern.
Feature-entropy Calculation
Based on the above calculation, it can be determined that
correct grouping can minimize the entropy difference for those
residues belonging to the ‘locally conserved’ case. To perform a
test, one sequence is selected while the rest of the sequences are
divided into a gastric cancer group and a non-cancer group. For
all selected residues, the selected sequence is placed into the gastric
cancer group to calculate the entropy difference DECA, and then it
is placed into non-cancer group to get the corresponding entropy
difference DENON{CA. Finally, DE0~DECA{DENON{CA is
obtained for all selected residues that are used as the feature
entropy.
Classification of CagA Sequences
Dataset. We searched the National Center for Biotechnology
Information (NCBI), the Swiss-prot/Tremble and DDBJ protein
database and obtained 535 strains of H. pylori CagA protein.
Among them, there are 287 East Asian subtype strains and 248
Western subtype strains. In the East Asian subtype group, 47 out
of 287 strains are from gastric cancer patients and the rest are from
other diseases. In the Western subtype group, there are 37 strains
from the gastric cancer patients, and the remainders are from
other diseases or the normal controls, including 24 strains from
volunteers whose health (disease) status was unknown.
Workflow. Figure 4 shows the workflow of the classification/
prediction procedure:
N Select one strain as the test strain.
N Apply a bootstrap procedure to the rest of the strains to get the
training strains.
N Calculate the feature entropy for the test strain based on
training strains and save it as the test data.
N Calculate the feature entropy for each strain in the training
strain set based on training strains and save them as the
training data.
N Generate classification model by using the training data.
N Classify the test data according to the classification model.
N Repeat this procedure five times, and then calculate the
average as the final result.
Bootstrapping. A major issue in building a classification
model in this case is the big difference of the sample sizes between
cancer and non-cancer groups, which could cause bias in the
classification results. A bootstrapping procedure was applied to
address this issue. In each subtype group, for each training/test
data sets, all non-cancer samples were included, and then strains
were continuously drawn from the cancer group on a random
basis until reaching the same size of the non-cancer group. In this
case, all the available data were used although cancer samples
were utilized multiple times given their smaller size compared to
the non-cancer group. This procedure was applied five times to
generate five independent training sets for each test sequence. The
classification/prediction result is the average of those five
independent results.
Cross-validation. Because the data size is small, a leave-one-
out (LOO) cross-validation procedure was performed. This is not
only an assessment of the classifier performance on training/test
data, but also an estimate of prediction power for novel cases.
SVM. We chose SVM as binary classifier and used the
feature-entropy vectors to train and test the classifier. In the case of
two-class soft margin classification, the decision function is a
weighted linear combination defined as follows:
f(x)~
X
xi[S aiyiK(x,xi)zb ð4Þ
Figure 1. Profiles of the CagA repeat regions.
doi:10.1371/journal.pone.0036844.g001
Figure 2. Structure examples: A-B-D and A-B-C types of CagA sequences (not on a proportional scale to sequence length).
doi:10.1371/journal.pone.0036844.g002
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measures the similarities between the input feature vector x and
the feature vectors xi in the training dataset S. ai is the weight
assigned to the training feature vector xi and yi indicates whether
a CagA strain has been labeled with the positive class (+1) or
negative class (21). The primal optimization problem takes the
form:minimize
t(w,j)~ 1
2 w kk
2z C
m
Pm
i~1 ji ð5Þ
subject to
yi SW xi ðÞ ,wTzb ðÞ §1{ji and ji§0 i~1,:::,m ðÞ ð6Þ
where WT xi ðÞ W xj
  
~K(xi,xj). m is the total number of strains. ji
is a slack variable which measures the degree of misclassification of
the datum. C is a cost parameter which allows for trading off
training error against model complexity. w is the normal vector
and b is the offset.
After comparing the results of polynomial, tanh and Gaussian
radial basis kernels, the result obtained with the RBF kernel
worked the best, where the Gaussian radial basis kernels (RBF:
exp({c xi{xj
       2)) are for general-purpose learning when there
is no prior knowledge about the data. The SVM
Light package
(http://svmlight.joachims.org/) [32] was employed to build our
application. The parameters C and c were tuned to get the best
model for the training data as shown in the following. All other
SVM parameters were set to their default values.
Performance evaluation. In order to evaluate the perfor-
mance of classifier, a variety of performance measures are applied:
accuracy, sensitivity and specificity. A true positive (TP) is a
cancer-related sequence classified as such, while a false positive
(FP) is a non-cancer related sequence classified as cancer-related, a
false negative (FN) is a cancer related sequence classified as non-
cancer related and a true negative (TN) is a non-cancer related
sequence classified as non-cancer related. The accuracy, sensitivity
(Sn), specificity (Sp) and Matthews correlation coefficient (MCC)
of classification is defined as follows:
Accuracy~
TPzTN
TPzFPzTNzFN
ð7Þ
Sp~
TN
FPzTN
ð8Þ
Sn~
TP
TPzFN
ð9Þ
Figure 3. An example to present different cases for the entropy
calculation.
doi:10.1371/journal.pone.0036844.g003
Figure 4. Workflow of classification/prediction procedure for
one specific CagA sequence.
doi:10.1371/journal.pone.0036844.g004
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TP|TN{FP|FN
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TPzFP ðÞ TPzFN ðÞ TNzFP ðÞ TNzFN ðÞ
p ð10Þ
Since there are only two parameters C,c ðÞ for the RBF kernel and
they are independent, we applied a grid-search to determine the
optimal parameters of classifier. We used a harmonic means of
sensitivity and specificity as the objective function to optimize the
performance of the model for the training set, which is defined as
follows:
F~
2 Sp|Sn ðÞ
SpzSn
ð11Þ
Results
Residue Detection and Feature Calculation
Table 1 lists all detected key residues by calculating the entropy
difference in each intervening region for both Western and East
Asian subtypes. Although there are some geographic variations of
CagA sequences between the Western and East Asian subtypes,
some common residues could still be found to distinguish the
cancer and non-cancer groups. It suggests that those residues
might be very important in determining the virulence of CagA and
the relation between CagA and some specific diseases.
The residue positions are shown in Figure 5. A previous study
[27] reveals that the different EPIYA segments can bind to the
different kinases, e.g., EPIYA-R2 and EPIYA-R3/R39 bind to the
C-terminal Src kinase (Csk) while EPIYA-R4 and EPIYA-R49
bind to the SHP-2 kinase to cause the hummingbird phenotype.
The CagA-Csk interaction down-regulates CagA-SHP-2 signaling
that perturbs cellular functions to control the virulence of CagA. It
is found that most detected residues belong to R2 and R3/R39
regions and few residues in R4/R4’ regions have been detected.
This may be because R4/R4’ has more conserved sequence than
R2, and R4/R49 is shorter than R3/R39. We suggest that the
different residue patterns in R2 or R3/R39 regions might change
the ability of down-regulating CagA-SHP-2 signaling, therefore
changing the virulence of CagA.
Ren et al. found that CagA multimerizes in mammalian cells
[33]. This multimerization is independent to the tyrosine
phosphorylation, but it is related to the ‘‘FPLxRxxxVxDLSKVG’’
motif which is named CM motif in the R39 intervening region.
Since the multimerization is a prerequisite for the CagA-SHP-2
signaling complex and subsequent deregulation of SHP-2, the CM
motif plays an important role in cagA-positive H. pylori-mediated
gastric pathogenesis. With multiple CM motifs H. pylori strains are
much likely associated with severe gastroduodenal diseases
[33,34], but this observation cannot explain why different
gastroduodenal diseases can be developed with the exact same
number of CM motifs. Our study detected two residues in the CM
motif of R39 intervening region, which might lead to the change of
multimerization, thus changing the virulence of CagA. This is in
consistent with a previous discovery [35] that the sequence
difference between the East Asian CM and the Western CM
determines the binding affinity between CagA and SHP-2.
While the key residues detected can reveal some difference
between cancer and non-cancer groups, no single residue can be a
Figure 5. Comparison of sequence profiles between cancer and non-cancer groups and selected features (residues marked with
arrows) based on entropy calculation in the R3’/R3 region.
doi:10.1371/journal.pone.0036844.g005
Table 1. Detected residues by calculating entropy difference
for each intervening region between Western and East Asian
subtypes.
Intervening regions Western subtype East Asian subtype
R2 1, 8, 10, 12 1, 8, 10, 12
R3’/R3 7, 8, 14, 35, 38 2, 4, 17, 31, 39, 48
R4’/R4 9, 14 16
doi:10.1371/journal.pone.0036844.t001
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one special combination of all or partial detected residues could
have a high correlation with one particular disease. To verify,
several linear statistical models, e.g. linear regression and logistic
regression, were applied to the detected features to evaluate the
importance of each residue and the correlation between selected
residues and cancer. However, none of above models were able to
produce a statistically significant result. Since the features cannot
be fitted by simple linear models for predicting cancer, applying a
machine learning method to analyze and classify these data
becomes necessary.
Parameter Training for Classification
Using the Western subtype group as the example, a loose grid-
search was first performed on C~2{5,:::,210 and c~2{10,:::,25
(Figure 6A) and found that the best C,c ðÞ is around 22,2{5   
to
get the highest F value with the LOO cross-validation rate 76%.
Then a finer grid search was conducted on the neighborhood
22,2{5   
and a better F value was obtained with 79.7% LOO
cross-validation at 22:25,2{4:75   
. The same procedure was utilized
for the East Asian subtype group and the best LOO cross-
validation rate 72.6% was reached at 22:25,2{4:75   
.
Since there are no previous studies or computational methods
on the same topic, evaluating the performance of this research’s
new method is difficult. To assess the information content of the
sequences in terms of their discerning power to predict cancer, a
random shuffling procedure was employed to build the control
group. First, all sequences from the Western subtype were placed
together to build a sequence pool. Second, we randomly picked
the same number of sequences as cancer group from the sequence
pool and treated the rest of the sequences as the non-cancer group.
Then, the whole training procedure was applied to newly shuffled
data to find the best C,c ðÞ . The above steps were repeated five
times to generate five independent shuffled data sets. The one with
the highest F value, which equals 46.6% was selected and its
contour plot is shown in Figure 6B. This randomly shuffling
evaluation was also applied to the East Asian subtype data and the
best F value was at 54.3%. Comparing the two plots shows the
significant difference of F values between the data with correct
grouping of cancer and non-cancer cases in training and the best
randomly shuffled data. The result suggests that the intervening
regions are informative to distinguish between the cancer and non-
cancer groups and our method can use the information effectively.
Classification Performance
There are mainly three categories of sequence classification
methods: feature based, sequence distance based and model based.
The method that we described in this paper belongs to the feature-
based category. We selected two of the most popular sequence
classification tools as the representative methods of other two
categories for comparison. BLAST [36] was chosen for the
sequence distance based category, since it is the most widely used
sequence comparison tool. For the model-based category, the
hidden Markov model is the typical method for sequence analysis
and its widely used tool, HMMER [37], was selected. For the
classification procedure of both BLAST and HMMER, we used
the default parameters of the tools, applied the same LOO cross-
validation as our method, and used the same evaluation formulas
listed in the Method section.
Table 2 lists the classification results for all three methods. The
SVM method performs significantly better than the other two
approaches. BLAST achieved close accuracy to the Entropy-SVM
method, but it predicted many false negatives with low sensitivity.
HAMMER achieved high sensitivity but with little specificity.
Considering F values and MCC values, the prediction results from
BLAST and HAMMER are almost random.
The classification result and the contour plot (Figure 6) strongly
support our hypothesis, i.e., the information of the selected
residues in intervening regions can be used to classify the relation
between CagA sequences and gastric cancer, although the
difference between the profiles of cancer and non-cancer groups
is not very strong.
Figure 6. Grid-search for determining the optimal parameters C,c ðÞ of classifier, with color indicating the F value. (A) The
contour plot of F value resulting from a loose grid-search on a hyper parameter range for the Western subtype group. (B) The contour plot of F value
resulting from a loose grid-search on a hyper parameter range for a randomly shuffled Western subtype group with the highest F value.
doi:10.1371/journal.pone.0036844.g006
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H. pylori infection is associated with most gastroduodenal
diseases, among which gastric cancer is the most severe one
causing more than 700,000 deaths worldwide every year [38].
Since H. pylori is a main risk factor of gastric cancer (GC),
discovery of the mechanism of H. pylori mediating GC becomes a
top priority task in this field. Comparing to other diseases, the
diagnosis information of GC from public data is relatively
accurate, and it is another important reason to focus on GC in
this paper. Our studies are not limited to GC, though. We also
tried to evaluate the relations between the variance of CagA
sequences and different diseases.
Since most data were collected from public databases without
accurate diagnosis information, before applying our method to
CagA data, we manually curated the disease annotations for all
strains by reviewing the literature. Table S1 lists the distributions
of major diseases for both the Western and the East Asain subtype
groups. Due to the limitation of strain numbers of some diseases,
such as atrophic gastritis (AG) and gastric ulcer (GU), we
eventually picked chronic gastritis (CG) and duodenal ulcer
(DU) as the control groups for evaluation. The DU group in the
East Asian subtype contains 79 strains, and a bootstrapping
procedure was applied to all other groups to make the same
number of strains as the East Asian DU group. This step
guarantees all comparisons on the same scale, since the value of
combinatorial entropy depends on the number of sequences. We
used Formula (3) to calculate the entropy difference of each
position between GC and CG/DU groups, and then added up all
entropy differences as the total difference between GC and CG/
DU groups, as shown in Table S2. By comparing results between
two groups within the same geographic subtype (East Asian or
Western subtype), it is consistent with the clinical view that gastritis
has stronger relations to cancer than to DU [39] (generally,
gastritis cases might contain some unreported or undiagnosed
chronic atrophic gastritis and intestinal metaplasia cases, with
which patients have a high risk to develop GC). By considering the
same disease-pair between two geographic subtypes, it also
explained the virulent difference between the East Asian and the
Western subtypes. In addition, due to the high similarity between
different disease groups of the East Asian subtype, even with more
data, we still cannot reach the same classification accuracy as the
Western subtype group.
Based on the above results, CagA sequences show potential to
distinguish multiple gastroduodenal diseases. In order to evaluate
the classification performance, we used DU group to replace non-
Cancer group, and then applied the whole classification procedure
again without bootstrapping, since those two diseases groups have
comparable sizes. Table S3 shows the classification results.
Although from the clinical point of view, DU has the negtive
correlation with GC among all gastroduodenal diseases [40], the
classification performance of two subtype groups was only slightly
improved. Thus cancer-related CagA strains might have some
unique sequence patterns comparing to all other gastroduodenal
diseases. Hence, tuning a subset of the control group may not be
able to improve the classification accuracy.
Discussion
Although research indicates that there are sequence markers to
differentiate between cancer group and non-cancer group, the
major profiles of those two groups are too similar to distinguish by
using traditional methods since the CagA sequences are overall
highly conserved. Therefore, we focused on identifying the
informative residues, quantifying information of these selected
residues, and then using it to design a classifier that can predict
whether a new sequence belongs to the cancer group or the non-
cancer group. This method not only sheds light on the relations
between CagA sequences and gastric cancer, but also may provide
a useful tool for gastric cancer diagnosis or prognosis.
The mechanisms of H. pylori causing the different gastroduode-
nal diseases are still unclear, however it is likely that various
gastroduodenal diseases caused by H. pylori infection share some
sequence patterns in the intervening regions. Small variations of
amino acids in those important residues might lead to the
virulence variance of CagA strains resulting in different gastrodu-
odenal diseases. While CagA could be a marker for detecting
potential cancer risk, using CagA alone to distinguish all
gastroduodenal diseases is not realistic. As a future study, we will
develop new models that differentiate various gastroduodenal
diseases from cagA and other genes.
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Table 2. Classification performance.
Subtype No. of cancer cases
No. of non-cancer
cases Method Sn Sp Accuracy F value MCC
Western 37 211 Entropy-SVM 0.86 0.74 0.76 0.80 0.45
BLAST 0.22 0.77 0.69 0.34 20.01
HMMER 0.94 0.005 0.14 0.009 20.16
East Asian 47 240 Entropy-SVM 0.74 0.71 0.71 0.73 0.35
BLAST 0.17 0.75 0.65 0.28 20.07
HMMER 1 0.003 0.19 0.05 0.06
doi:10.1371/journal.pone.0036844.t002
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